Psych Vivas · General adult psychiatry — psychotic disorders
Schizoaffective disorder — structured clinical viva
Fellowship viva on schizoaffective bipolar type criteria, discrimination from schizophrenia and bipolar with psychosis, antidepressant pitfalls, lithium/antipsychotic strategy, and suicide risk.
On this page & tools
Target exams
Interpretation
Reveal interpretation
Rebuild the life-chart before defending any label. The history of mania plus a full month of delusions while euthymic is the critical discriminator against pure bipolar with psychosis confined to mood episodes. If mood episodes occupy the majority of total illness duration and Criterion A symptoms have been concurrent with mood, schizoaffective disorder, bipolar type is the operational diagnosis — not “schizophrenia with a bit of mood.”[1]
Acute management treats mania and psychosis together: safety, sleep, legal status, antimanic antipsychotic ± lithium/valproate, stop unprotected antidepressant (sertraline without mood-stabiliser cover is a red flag in bipolar-type illness).[2][4]
Longer-term plan: antipsychotic adherence strategy, polarity-safe maintenance (lithium if suitable — anti-suicide evidence in mood disorders), metabolic monitoring, cannabis/substance review, family psychoeducation. Clozapine enters if high suicidality or TRRIP resistance.[3][5][4]
Escalating questions (model answers)
1. Why not bipolar I with psychotic features?
Because psychosis persisted for a month after mood resolution — the ≥2-week psychosis-without-mood rule is met. Bipolar with psychosis confines psychosis to mood episodes.[1]
2. Why not schizophrenia?
If major mood syndromes truly occupy the majority of total active and residual duration, schizophrenia (mood as minority) is less accurate. Confirm with collateral and records; if mood was only brief relative to years of pure psychosis, keep schizophrenia.[1]
3. What will you do with sertraline today?
Hold/stop antidepressant monotherapy risk in bipolar-type illness while mania is active. Restart any antidepressant later only with antipsychotic/mood-stabiliser cover, short intentional duration, and polarity monitoring — many patients need none once psychosis and polarity are controlled.[4][2]
4. Name a drug, dose framework, and monitoring for tonight’s mania + psychosis.
Example: olanzapine 10 mg oral (titrate toward 10–20 mg) with metabolic baseline, plus consider lithium start 400–800 mg/day with eGFR/TFT and 12-hour trough plan, or ensure antimanic SGA cover alone if lithium unsuitable. Document QTc/ECG as indicated. Restore sleep; de-escalate environment.[2][3][4]
5. Where does InterSePT fit if he develops severe suicidal behaviour?
InterSePT supports clozapine over olanzapine for suicidal behaviour in schizophrenia spectrum including schizoaffective disorder — still combine with means restriction and service intensity.[5]
Key points
[1] [4]References
- [1]Malaspina D, Owen MJ, Heckers S, et al. Schizoaffective Disorder in the DSM-5 Schizophr Res, 2013.PMID 23707642
- [2]Tohen M, Zhang F, Keck PE, et al. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type J Affect Disord, 2001.PMID 11869760
- [3]Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ, 2013.PMID 23814104
- [4]Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders Aust N Z J Psychiatry, 2016.PMID 27106681
- [5]Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) Arch Gen Psychiatry, 2003.PMID 12511175